BRIUMVI is currently approved in the United States, as well as several countries outside of the U.S., as a one-hour intravenous (IV) infusion administered twice a year, following the starting dose, in ...
The EPIC study will evaluate treatment with IMAAVY™ versus efgartigimod in adults with gMG and will include a treatment-switch arm The Company also announced new data from the pivotal Vibrance-MG ...
TG Therapeutics, Inc. (NASDAQ: TGTX), announced today that enrollment has completed in the randomized cohort of the Phase 3 ENHANCE trial evaluating a consolidated ...
Hyperion Surgical, Inc. today announced the successful completion of the world’s first robotic-assisted intravenous (IV) catheterization using its Ivy™ robotic vascular access platform, which ...
First-in-Human Phase 1 data for allogeneic CAR-T cell therapy for NHL to be featured in oral session ...
United Therapeutics Corporation today announced the first clinical xenotransplantation in its EXPAND study of the UKidneytm in patients with end-stage renal disease (ESRD). The successful transplant ...
Chennai: AI-enabled scan machines are increasingly used by city hospitals to alert radiologists about problem areas in brain ...
News Medical on MSN
Home treatment with IV antibiotics could relieve NHS pressure
Researchers have found that treating patients at home with IV antibiotics could halve costs to the NHS and relieve pressure ...
Q3 2025 Earnings Call October 28, 2025 8:00 AM EDTCompany ParticipantsAlexis SmithWilliam Meury - CEO, President ...
Merck and Eisai Provide Update on Phase 3 LEAP-012 Trial in Unresectable, Non-Metastatic Hepatocellular Carcinoma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback